CVS Health (CVS) Tops Q3 EPS by 1c; Narrows EPS Outlook, Raising Midpoint
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
CVS Health (CVS) PT Lowered to $76 at Jefferies Following 3Q
November 7, 2017 8:24 AM ESTJefferies lowered its price target on CVS Health (NYSE: CVS) to $76.00 (from $86.00) while maintaining a Hold rating. CVS reported Q3 EPS of $1.50 that beat consensus by $0.02. Similar to the last few quarters, SSS revs were pressured by weakness in front-end sales and the... More
CVS Health (CVS) PT Lowered to $85 at Leerink Partners
November 7, 2017 7:48 AM ESTLeerink Partners lowered its price target on CVS Health (NYSE: CVS) to $85.00 (from $90.00) while maintaining an Outperform rating.
Analyst David Larsen notes volumes starting to show some improvement and the company is responding aggressively to Amazon.
In the quarter same-store... More
